Pre-Test Implementing Evidence-Based Treatment in Alcohol Use Disorder Pre-Test Which of the following is a recommended first-line treatment option in the ED for mild to moderate alcohol withdrawal symptoms (AWS)? Gabapentin Lorazepam Naltrexone Phenobarbital Unsure Which of the following is available as an FDA-approved extended-release formulation for AUD maintenance? Acamprosate Disulfiram Lorazepam Naltrexone Unsure
